In vitro, disruption of Stat5a, but not Stat1, which exhibited a positive correlation with cGAS regardless of TET2 expression (Fig. 6g), impaired Cgas expression in liver cancer cells (Fig. 6h, i). The gene discussed is STAT5A; the disease is liver cancer.